(EMAILWIRE.COM, December 28, 2017 ) Migraine is characterized by recurring headaches and throbbing pain on one side of the head accompanied by nausea, vomiting, or increased sensitivity to light or smell. While most migraineurs experience episodic migraines (EM), a small percentage suffers from chronic migraine (CM). In addition to its debilitating pain, migraines are also associated with more severe cardiovascular and neuropsychological comorbidities. Because migraine is one of the most prevalent types of headache, there is a substantial economic and social burden associated with the condition worldwide, and it is therefore recognized as a high-priority public health problem by the World Health Organization.

In 2016, there were 73,914,635 total prevalent cases of migraine in adults ages 18 years and older in the 7MM. The US had the most cases, while Spain had the fewest. In the 7MM, the number of total prevalent cases of migraine is expected to grow to 74,543,569 by 2026, at an Annual Growth Rate (AGR) of 0.09%. Since age-and sex-specific prevalence was held constant throughout the forecast period, all changes in the total prevalent cases of migraine are the result of demographic changes. Publisher epidemiologists estimate that 1.61% of total migraine cases in the 7MM in 2016 were CM.

Request a Sample Report@ http://www.reportsweb.com/inquiry&RW00011065328/sample

This forecast is supported by country-specific prevalence studies for each market, most of which are based on nationally representative samples. Publisher epidemiologists are confident that these sources provide the most accurate and robust data available in each market. Additionally, Publisher epidemiologists used consistent methodology while creating forecasts for each market. This allows useful and accurate comparisons regarding total prevalent cases of migraine between markets.

Report Scope:
-The Migraine EpiCast Report provides an overview of the risk factors and global trends of migraine in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan). It includes a 10-year epidemiological forecast for the total prevalent cases of migraine segmented by sex and age (for ages 18 years and older) in these markets. This forecast is further segmented by migraine frequency into episodic migraine (EM) and chronic migraine (CM).
-The migraine epidemiology report is written and developed by Masters-and PhD-level epidemiologists.
-The EpiCast Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to buy:
The Migraine EpiCast report will allow you to-
-Develop business strategies by understanding the trends shaping and driving the global migraine market.
-Quantify patient populations in the global migraine market to improve product design, pricing, and launch plans.
-Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for migraine therapeutics in each of the markets covered.
-Identify the percentage of migraine prevalent cases by frequency.

Inquire before Buying@ http://www.reportsweb.com/inquiry&RW00011065328/buying

Table of Contents:
1. Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3
2 Executive Summary 4
2.1 Related Reports 5
2.2 Upcoming Reports 5
3 Epidemiology 6
3.1 Disease Background 6
3.2 Risk Factors and Comorbidities 6
3.3 Global and Historical Trends 9
3.3.1 US 10
3.3.2 5EU 11
3.3.3 Japan 11
3.4 Forecast Methodology 11
3.4.1 Sources 12
3.4.2 Forecast Assumptions and Methods 14
3.5 Epidemiological Forecast for Migraine (2016-2026) 17
3.5.1 Total Prevalent Cases of Migraine 17
3.5.2 Age-Specific Total Prevalent Cases of Migraine 18
3.5.3 Sex-Specific Total Prevalent Cases of Migraine 19
3.5.4 Migraine Cases by Frequency of Occurrences 20
3.6 Discussion 21
3.6.1 Epidemiological Forecast Insight 21
3.6.2 Limitations of Analysis 22
3.6.3 Strengths of Analysis 23
4 Appendix 24
4.1 Bibliography 24
4.2 About the Authors 28
4.2.1 Epidemiologist 28
4.2.2 Reviewers 28
4.2.3 Global Director of Therapy Analysis and Epidemiology 29
4.2.4 Global Head and EVP of Healthcare Operations and Strategy 29
4.3 About GlobalData 30
4.4 Contact Us 30
4.5 Disclaimer 30

For more information about this report@ http://www.reportsweb.com/epicast-report-migraine-epidemiology-forecast-to-2026

Contact Information:
ReportsWeb.com
Rajat Sahni
Tel: +1-646-491-9876
Email us


----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results